NHS

NanoVibronix Issues Letter to Stockholders

Retrieved on: 
火曜日, 4月 9, 2024
Medical Devices, Health, Health Technology, Research, Science, Biotechnology, National Health Service, Growth, Partnership, COVID-19, Patient, SAW, Gold, NHS, University, University of Michigan, Quality of life, Insurance, GSA, Urinary tract infection, Pain, Medicare, FDA, CMS, Engineering, Food, Pharmaceutical industry

We are focused on several areas that we believe will have a substantial impact on our growth and product adoption.

Key Points: 
  • We are focused on several areas that we believe will have a substantial impact on our growth and product adoption.
  • A driving factor in our increased revenues was increased sales to customers using the Veterans’ Health System and worker’s compensation plans.
  • On our balance sheet for the period ended December 31, 2023, we had $3.3 million of cash and inventory of $2.7 million.
  • CMS invited NanoVibronix to a public meeting to present its findings and to answer CMS’s questions, which was held June 1, 2023.

Germany decriminalised cannabis: why the UK should consider doing the same

Retrieved on: 
火曜日, 4月 9, 2024
Depression, Quality control, Psychosis, Health, Incidence, Risk, Ageing, Public, Mental health, Research, NHS, Stroke, Policy, Tobacco, Smoke, Office for National Statistics, Cannabis, Woman, Plant, Smoking, Cancer, Conservatism, Public health, Government, Legislation, Drug

This policy allows over-18s to possess a maximum of 25 grams of cannabis for personal use and grow up to three plants at home.

Key Points: 
  • This policy allows over-18s to possess a maximum of 25 grams of cannabis for personal use and grow up to three plants at home.
  • The UK government cites concerns about the risk to mental health associated with using cannabis as a justification for supporting prohibition.

Cannabis and mental health

  • There is extensive research exploring the relationship between cannabis and mental health problems, such as psychosis.
  • The evidence suggests that some people may be more vulnerable than others to developing psychosis through cannabis use.
  • The risk to mental health associated with cannabis, then, is relatively low.

Alcohol and tobacco: regulated but riskier

  • Unlike cannabis, alcohol is regulated in the UK.
  • As with cannabis, there are risks to mental health as a consequence of using alcohol.
  • The risk of developing depression among heavy alcohol use is significant: one in two will experience depression.
  • So despite alcohol being regulated or legal, the risks to a person’s mental health are greater than those posed by cannabis.

Public health

  • In contrast, German policy reform includes a public health education programme which aims to reduce the risks of using cannabis.
  • In 2007, when the Labour government introduced a ban on smoking in public areas, this wasn’t supported by many people.
  • The risks to health from using cannabis, then, are relatively small compared to regulated drugs such as alcohol and tobacco.
  • As the UK public finances continue to be squeezed, particularly around the NHS, persisting with the prohibition of cannabis is a missed opportunity for the nation’s health and a costly policy for its public services.


Mark Monaghan receives funding from UK Government, Cabinet Office and the ESRC. He has in the past received funding from the Nuffield Foundation. Ian Hamilton does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

More mental health support in schools makes sense – but some children may fall through gaps

Retrieved on: 
火曜日, 4月 9, 2024
Risk, Poverty, Education, Mental, School, Mental health, NHS, Functional analytic psychotherapy, Government, Parent, Research, Anxiety, CBT, Violence, Nursing

This is something the government has been doing in England through the creation of mental health support teams.

Key Points: 
  • This is something the government has been doing in England through the creation of mental health support teams.
  • The first 58 mental health support teams went live in 2020, working in and with more than 1,000 schools and colleges.
  • Mental health support teams are intended to provide support to young people with “mild to moderate” mental health difficulties, such as anxiety and low mood.
  • This is a new role in the mental health workforce, created specifically for mental health support teams.
  • We also spoke to young people at schools with mental health support teams.

Through the gaps

  • We heard that some young people were at risk of falling between gaps in provision.
  • They had mental health problems that were neither “mild to moderate”, nor were they judged serious or urgent enough to meet the threshold for specialist NHS help.
  • I am now co-leading a second, much larger, study of almost 400 mental health support teams, assessing their impact and cost-effectiveness.
  • As the study progresses, we will know more about how well this support works and who it works for.


Jo Ellins receives funding from the National Institute for Health and Care Research.

UK AI Firm Quantexa, Mersey Care NHS Foundation Trust, and the University of Liverpool’s Civic Health Innovation Labs Partner to Create a Groundbreaking Global AI Hub for Health and Social Care in Liverpool

Retrieved on: 
月曜日, 3月 18, 2024
Civic, OLS, Health, Innovation, Associate, Mental, Partnership, University of Liverpool, Caregiver, Patient, Mental health, NHS, University, AI, Private sector, Social work, Ecosystem, Health and social care, Engineering, Nursing

Based within CHIL is the Mental Health Research for Innovation Centre (M-RIC), a partnership between Mersey Care NHS Foundation Trust and the University of Liverpool, aimed to tackle global challenges in mental health, including increasing levels of illness.

Key Points: 
  • Based within CHIL is the Mental Health Research for Innovation Centre (M-RIC), a partnership between Mersey Care NHS Foundation Trust and the University of Liverpool, aimed to tackle global challenges in mental health, including increasing levels of illness.
  • It will support building a trusted data foundation to develop better drug and digital therapies, as well as to better coordinate care services.
  • Quantexa will be working alongside teams from the University of Liverpool, NHS Cheshire and Merseyside Integrated Care Board, and Mersey Care NHS Foundation Trust.
  • Vishal Marria, CEO of Quantexa, said: “Quantexa’s vision is to work with university and NHS partners to address global current challenges in UK care programs.

Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold

Retrieved on: 
火曜日, 3月 12, 2024
Syndrome, Health, National Health Service, ROI, Congress, LTD, Rheumatology, Bone disease, Data analysis, Risk, Patient, Fracture, VCF, NHS, Abdomen, Hospital, Research, AI, University, Systematic review, Treatment, Spine, FLS, Family, FDA, Vertebral compression fracture, University of Oxford, Medical device

PETACH TIKVA, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, and its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd. (Nanox.AI), today announced that early findings from the AI-enabled Detection of OsteoPorosis for Treatment (ADOPT) study, which uses a Nanox.AI artificial intelligence solution, HealthVCF, to review routine CT scans, have identified up to six times more patients with vertebral compression fracture than the national average at National Health Services (NHS) hospitals in the UK, which include University of Oxford and other healthcare centers.

Key Points: 
  • Thus far in the study, the Nanox.AI algorithm has identified over 2,400 patients with VCF from routine CT scans that were not known to the NHS’s hospitals, and have since been flagged for follow-up assessments.
  • “Leveraging AI-powered population health solutions presents an effective and efficient avenue for early identification of patients at very high risk of fractures, facilitating timely intervention and care.
  • As such, there have been efforts to introduce FLS into public health systems.
  • The next-generation HealthOST received FDA 510(K) clearance in April 2022.

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
木曜日, 3月 28, 2024
Oncology, Health, FDA, Clinical Trials, Pharmaceutical, Biotechnology, Diagnosis, De novo, PIN, Obesity, MRI, Syndrome, Metabolism, KCH, Knowledge Organization (journal), International, National Health Service, NHS, Research, Radiology, MASH, Trial of the century, International Classification of Diseases, Hepatology, World Health Organization, Data collection, Prediabetes, NDRA, Liver, Type 2 diabetes, Liver disease, Marketing, NAFLD, Endocrinology, Video game

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update.

Key Points: 
  • ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update.
  • Highlights from the fourth quarter of 2023 and recent weeks include:
    Installed first TAEUS system in the UK at King’s College Hospital for clinical evaluation.
  • In the third quarter of 2023, ENDRA submitted a De Novo request for its TAEUS liver system to the FDA.
  • In the fourth quarter of 2023, the FDA issued an Additional Information (AI) request to ENDRA.

Teva UK and Closed Loop Medicine Announce Strategic Partnership to Advance Development of Personalised Medicines

Retrieved on: 
火曜日, 3月 26, 2024
Software, Biotechnology, Pharmaceutical, Health, Medical Devices, Health Technology, Technology, Clinical Trials, Disease, Ulcerative colitis, Risk, Partnership, Patient, NHS, Mortality, Pivot, Pharmacotherapy, Investment, Clinical trial, Annual report, Inflammatory bowel disease, Teva, Therapy, Hypertension, Medicine, Pharmaceutical industry

Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.

Key Points: 
  • Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.
  • Under the agreement, Closed Loop Medicine – a leading TechBio company – and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicine’s proprietary software as a medical device (SaMD) technology platform which aims to advance the development of personalised medicines, improve drug efficacy and outcomes in patients with specific chronic disorders by combining dose-optimised drug therapy with digital care.
  • Dr Paul Goldsmith, Chief Medical Officer and Innovation Officer, Co-Founder and President of Closed Loop Medicine, said: “As clinicians, we know that dosing of drugs is a huge problem.
  • Being able to predict personalised dose levels could be transformational.”
    This strategic partnership harnesses Closed Loop Medicine’s proprietary SaMD and combines it with Teva’s pharmaceutical products creating the opportunity for digital companions to be prescribed alongside traditional therapeutics, enabling real-world data integration and improved effectiveness of innovative and known medicines.

Jackery to Power Up the National Hardware Show (NHS) with Innovative Solar Solutions

Retrieved on: 
月曜日, 3月 25, 2024
Home Goods, Building Systems, Residential Building & Real Estate, Retail, Alternative Energy, Construction & Property, Green Technology, Energy, Sustainability, Manufacturing, Environment, Other Retail, Other Manufacturing, Machinery, Other Energy, Other Construction & Property, Transfer, Emergency, Electricity, Solar, E1000, Gardening, Exploration, Lithium iron phosphate, Light, NHS, DIY, LFP, Sustainable energy, Booth, National Hardware Show, Renewable energy

Among the highlights of Jackery's showcase will be the Solar Generator Home Kit 400W (Auto Transfer Switch+4kWh+200W*2) and the Solar Generator 1000 Plus 100W (Explorer 1000 Plus+100W).

Key Points: 
  • Among the highlights of Jackery's showcase will be the Solar Generator Home Kit 400W (Auto Transfer Switch+4kWh+200W*2) and the Solar Generator 1000 Plus 100W (Explorer 1000 Plus+100W).
  • Jackery Solar Generator Home Kit 400W: Your Reliable Home Back-Up Companion
    The Jackery Solar Generator Home Kit 400W (Auto Transfer Switch+4kWh+200W*2) offers an all-in-one power backup solution perfect for home use, DIY projects, and professional needs.
  • "At Jackery, we understand the importance of reliable power solutions, especially during home improvement work and home DIY projects," said David Bai, Head of R&D Center at Jackery.
  • Experience the future of solar generators firsthand at the National Hardware Show as Jackery showcases its groundbreaking innovations, setting new standards in reliability, sustainability, and versatility.

Hyve Managed Hosting Launches Germany Hub in Berlin

Retrieved on: 
月曜日, 3月 18, 2024
Data Management, Security, Technology, Software, Networks, Internet, Cloud, DACH, Culture, Growth, Konica Minolta, Digitalization, NHS, Disaster recovery, Dedicated, Service, SDC, Brexit, Cloud computing, Ansys

Hyve Managed Hosting , a global, fully managed hosting provider, is bringing its award-winning cloud expertise to Germany and the DACH market with the opening of its new European hub in Berlin.

Key Points: 
  • Hyve Managed Hosting , a global, fully managed hosting provider, is bringing its award-winning cloud expertise to Germany and the DACH market with the opening of its new European hub in Berlin.
  • In the market dominated by hyperscalers, Hyve Managed Hosting GmbH aims to bring organisations in the region a much-needed individualised approach, offering high-performance cloud hosting solutions with truly personalised management and support.
  • Hyve Managed Hosting is a global, fully managed hosting provider with a passion for exceptional customer service.
  • Adopting a customer-centric approach, Hyve delivers a range of managed hosting services, from mission-critical private cloud and enterprise cloud to colocation and security services.

New Victoria Hospital Selects MEDITECH Expanse to Advance Patient-Centric Care

Retrieved on: 
木曜日, 3月 14, 2024
Data Management, Practice Management, Technology, Health, Health Technology, Apps, Applications, Software, Artificial Intelligence, Hospitals, Networks, Audio, Video, Cloud, MEDITECH, GCP, Freedom, Longevity, EPR, Partnership, Patient, Hospital, NHS, AI, Google Cloud Platform, New Victoria Hospital, Multimedia

Ranked one of London’s top private hospitals by patients, New Victoria Hospital (London, UK) has signed for MEDITECH Expanse to advance care delivery and remain competitive in a rapidly changing healthcare market.

Key Points: 
  • Ranked one of London’s top private hospitals by patients, New Victoria Hospital (London, UK) has signed for MEDITECH Expanse to advance care delivery and remain competitive in a rapidly changing healthcare market.
  • View the full release here: https://www.businesswire.com/news/home/20240314609949/en/
    “Technology is vital to the future of healthcare,” said New Victoria Hospital CEO David Marshall .
  • “The implementation of Expanse will deliver a more complete patient record, enabling us to provide more comprehensive and informed care to our community.”
    New Victoria Hospital’s Expanse EPR will be hosted on Google Cloud Platform (GCP) through MEDITECH UK.
  • “It’s exciting to see this partnership moving forward, and to anticipate all the benefits that New Victoria Hospital and MEDITECH will achieve together.”